VICKI is an IoT self-checkout solution for regulated retail, powered by artificial intelligence, with secure data storage and verification

Chemesis International Inc. (CSE:CSI)(OTC:CADMF)(FRA:CWAA) (the “Company” or “Chemesis”), announces its initial deployment of its VICKI Artificial Intelligence Self-Checkout Solutions at Atlanta International Airport, the world’s most efficient and busiest airport, with over 110 million passengers in 2019.[1


In collaboration with Business Traveler Services, Inc., a minority-owned airport concessionaire of Atlanta International Airport, Chemesis International with its partner ViaTouch Media Inc, has launched branded CBD automated retail stores in Concourses A & D. Under our retail brand, Green Spirit Rx, which deploys unattended retail stores, offering consumers CBD products and Personal Protective Equipment.

Through advanced technology leveraging artificial intelligence, video and voice education, creates a strong consumer engagement experience. Green Spirit Rx brings the highest quality, certified brands to market with the ability for consumers to benefit while they are on the go with travel size personal care packages. The VICKI was initially deployed prior to the pandemic, serving as a proof of concept for the Company’s unattended route to market. Chemesis and its management team are now confident in the ability to scale this retail channel throughout airports, shopping centres, arenas, and other high traffic areas.

“At Chemesis International, we believe a safe, informed consumer experience gives our consumers the ability to interact and transact in a manner in which they prefer to build a relationship with our brands, in this category. The on the go consumer depends on proximity and ease of transaction as a requirement to capture their share of wallet. We believe we are best positioned to bring our brands closer to the consumer under this platform”, says Josh Rosenberg, President of Chemesis.

“Business Traveler Services was the first company to understand the demand for CBD products within the travel sector. It established the first CBD retail store in any US Airport at Hartsfield-Jackson Atlanta International Airport. Chemesis has proven they understand our consumers, represent certified products, and leveraging the right technology to meet our consumer needs. Early results support our decision to expand this relationship and we look forward to being a preferred outlet for our travelers”, says Anita Leopold, partner of Business Traveler Services.

For more information regarding VICKI, please visit, https://getvicki.com

On Behalf of The Board of Directors
Josh Rosenberg
President

About Chemesis International Inc.

Chemesis International Inc. is a vertically integrated U.S. Multi-State and Multi-National Operator.

The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. Chemesis leverages a portfolio of brands to develop strong brand loyalty and customer retention. The Company is focused on scalable growth within its business operations; this includes its retail strategy of coalescing dispensary and alternate routes to market.

Chemesis and its team are committed to building a strong unattended and attended retail model for the cannabis market across the United States and Puerto Rico. Chemesis’ retail brand, Green Spirit Rx, will continue to provide consumers with industry-leading technology, the most sought-after products and education.

Investor Relations:

ir@chemesis.com
1 (604) 398-3378

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing, including with respect to the Company’s expectations regarding its supply and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected, including, but not limited to, in relation to executing on and maintaining its supply and distribution arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

[1] The Busiest Airport in the World 2018

View source version on accesswire.com:
https://www.accesswire.com/608666/Chemesis-International-Inc-Announces-Initial-Deployment-of-its-VICKI-Artificial-Intelligence-Self-Checkout-Solution-at-Atlanta-International-Airport

News Provided by ACCESSWIRE via QuoteMedia

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less